NEW YORK (Reuters Health) – Buprenorphine-naloxone (Suboxone, Reckitt-Benckiser) helps curb
prescription opioid dependence, but additional counseling does little to boost success rates, according to results
of a randomized controlled trial published online November 7 in Archives of General Psychiatry. (Source: Modern Medicine)
MedWorm Sponsor Message: Please support the DoctorsInChains.org campaign for the health workers in Bahrain. #FreeDoctors
